Category: Pharmaceuticals
Roche is working closely with FDA to make this potential new personalized medicine available as soon as possible. Roche, the Swiss multinational healthcare company, has been recently reported to …
The study found that about 90% of patients receiving the drug combination therapy turned out to be alive after 12 months. Merck & Co. Inc. and Pfizer Inc. are …
Summit Therapeutics, a clinical-stage drug development company based in the UK, has reportedly proclaimed that its first patient has been dosed in the global Phase 3 clinical trials of …
The acquisition is expected to be highly earnings enhancing for the commercial medicines division as well as the whole group. Clinigen Group, the multinational pharmaceutical and services company, has …
The drug has specifically been developed for treating acquired Thrombotic Thrombocytopenic Purpura in adult patients. Cablivi’s efficacy was studied in a clinical trial which saw participation from over 145 …
Swisshealthcare company Roche will reportedly be donating its new hemophilia A drugHemlibra for a World Hemophilia Federation program, the company said.Apparently, Roche will be joining its rivals who also …
Roche, a Swiss multinational healthcare company, has reportedly announced its plans to broaden breast cancer treatment with the newer breast cancer drug Kadcyla. The move comes in the wake …
The CHMP (Committee for Medicinal Products for Human Use), owned by the European Medicines Agency (EMA), has recommended approval for Praluent (alirocumab), a drug developed by Sanofi and the …
The investment will help support Solara Active’s expansion in its regulated markets and is expected to close in early 2019, subject to regulatory and shareholder approval. Renowned private equity …
In close collaboration with WARF, Invenra’s SNIPER™ technology is expected to help create antibody-based therapies to advance pediatric neuroblastoma treatment Invenra, a Wisconsin-based biotechnology company, has reportedly entered into …
